-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2024.
- Inhibikase Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.65 USD/shares, a 24.4% increase year-over-year.
- Inhibikase Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -2.66 USD/shares, a 45.6% increase year-over-year.
- Inhibikase Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.57 USD/shares, a 16.6% increase from 2022.
- Inhibikase Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.28 USD/shares, a 428% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)